News

Researchers hope MindGlide will unlock valuable information from millions of untapped brain images that were previously difficult or impossible to understand.
A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with ...
The new test could help identify which patients are most likely to benefit from new Alzheimer’s drugs. A newly developed ...
Proving causation is a challenge in healthcare, legal cases, and scientific research. How can professionals confirm that an ...
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...
A new study highlights that olfactory testing could offer a simple, cost-effective way to detect early cognitive impairment ...
Genetics researcher Jonathan Rios talks about his research to test a gene therapy for a rare neurological disease in children called childhood-onset striatonigral degeneration, at Dallas Scottish ...
The United States government has discontinued its free at-home COVID-19 test program after four years. The program, which began in 2021, shipped over 900 million tests directly to U.S. households.
I see the value in the focus tracking features the MW75 Neuro provide. Is this an expensive, niche product? Absolutely. But getting a high-quality set of headphones paired with tools to help me ...
Now, researchers at the University of Florida and the UF Health Norman Fixel Institute for Neurological Diseases have developed a new kind of software that will help clinicians differentially diagnose ...
I’m 42, but I traveled some 500 miles today to rectify something missing from my childhood, when I sought answers in vain about a neurological ... I decide to test his hypothesis.
A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a $10 million investment from several life sciences companies under South ...